A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years (Q44024537)
Jump to navigation
Jump to search
scientific article published in June 2012
- A Global Risk Approach to Identify Patients With Left Main or 3-Vessel Disease Who Could Safely and Efficaciously Be Treated With Percutaneous Coronary Intervention
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years |
scientific article published in June 2012 |
|
Statements
1 reference
A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years (English)
1 reference
1 reference
Patrick W Serruys
1 reference
Marie-Claude Morice
1 reference
Hector M Garcia-Garcia
1 reference
Pascal Vranckx
1 reference
Michael J Mack
1 reference
Arie-Pieter Kappetein
1 reference
Keith D Dawkins
1 reference
Marie-Angèle Morel
1 reference
Chrysafios Girasis
1 reference
Ted Feldman
1 reference
Friedrich W Mohr
1 reference
Stefan James
1 reference
Elisabeth Ståhle
1 reference
Salvatore Brugaletta
1 reference
Gerrit-Anne Van Es
1 reference
David R Holmes
1 reference
Antonio Colombo
1 reference
Peggy Pereda
1 reference
Jian Huang
1 reference
1 June 2012
1 reference
1 reference
Identifiers
1 reference